Methylene Blue Inhibits Fatty Acid Oxidation And Improve Metabolic Flexibility In The Heart

Discussion in 'Supplements, Pharmaceutical Drugs' started by Hans, Feb 21, 2019.

  1. Hans

    Hans Member

    Joined:
    Aug 24, 2017
    Messages:
    932
    Gender:
    Male
    Methylene blue decreases mitochondrial lysine acetylation in the diabetic heart
    "Our results also indicate that decreased lysine acetylation of FA oxidation enzymes with MB treatment positively correlates with a decrease in the overall FA β-oxidation pathway, suggesting a protective effect of this compound on the excessive reliance of the heart on FA oxidation in diabetes."

    It does so by lower the activity of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase enzyme.

    The dose was 10mg/kg in the rats, which would be about 1.43mg/kg in humans. It's a bit high dose, but methylene blue accumulates in the mitochondria and could possibly be achieved by long term use at smaller doses.
     
Loading...